PLGO | Ticker Profile - Titan Protect

PLGO

Pelagos Insurance Capital Limit

Financial Services · Insurance - Diversified · NYQ

$21.81

Data: 2026-05-28

✗ ETHICAL FAIL

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$1.9B

Total market value of the company

Trailing P/E

6.05

Very cheap relative to earnings

Forward P/E

5.41

Based on estimated future earnings — lower means cheaper

Rev Growth

-7.3%

Year-over-year revenue change

Profit Margin

15.3%

How much profit the company keeps from each dollar of revenue

ROE

16.2%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$23.00

+5% from current price — median analyst estimate

Recommendation

HOLD

Consensus view from 9 analysts covering this stock

About Pelagos Insurance Capital Limit

Pelagos Insurance Capital Limited provides insurance and reinsurance solutions in Bermuda, the Republic of Ireland, and the United Kingdom. It operates in two segments: Insurance and Reinsurance. The Insurance segment offers property, marine, asset backed finance and portfolio credit, aviation and aerospace, political risk, violence and terror, energy, cyber, and other insurance risks products. The Reinsurance segment provides property, retrocession, and whole account reinsurance solutions. The company was formerly known as Fidelis Insurance Holdings Limited and changed its name to Pelagos Insurance Capital Limited in May 2026. Pelagos Insurance Capital Limited was incorporated in 2014 and is headquartered in Pembroke, Bermuda.

https://www.pelagosinsurancecapital.com

Country: Bermuda Employees: 108 Industry: Insurance - Diversified

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

FAIL

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% N/A

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

0.741

Good returns relative to risk taken

Kelly Fraction

0.0379

Modest edge detected — smaller position warranted

Calmar Ratio

0.654

Acceptable balance between returns and drawdown risk

Annual Return

19.6%

Historical annualised return based on price data

Max Drawdown

-29.9%

Largest peak-to-trough decline — the worst it has been

HMM State

CRISIS

Elevated risk detected — extreme caution warranted

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.37

Very low correlation to market moves

52W High

$24.06

9% below the year high

52W Low

$14.80

47% above the year low

Avg Volume

458,636

Average daily shares traded — higher means easier to buy and sell

Short Ratio

4.1

Days it would take all short sellers to cover — higher means more crowded

Short % Float

2.5%

Low short interest — limited bearish positioning

Div Yield

272.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$3.64

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

37.42

Heavy leverage — higher financial risk if revenues decline

Current Ratio

1.15

Adequate but worth monitoring

Quick Ratio

0.68

Like current ratio but excludes inventory — stricter test

Gross Margin

23.9%

Revenue left after cost of goods — higher means pricing power

Operating Margin

19.3%

Profit from core operations before interest and tax

Free Cash Flow

$841M

Positive — the business generates more cash than it spends

Revenue (TTM)

$2.5B

Total revenue over the last 12 months

Net Income

$376M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$28.00

Target Median

$23.00

Target Low

$20.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go